Clinical trial
A Multi-Center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of FST-100 Ophthalmic Suspension in the Treatment of Acute Viral Conjunctivitis
NCT01461954 is registered in ClinicalTrials.gov with Shire as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of FST-100 Ophthalmic Suspension in the Treatment of Acute Viral Conjunctivitis
- Lead sponsor
- Shire
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 17, 2013
- Completion date
- March 10, 2014
- Enrollment
- 132 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acute viral conjunctivitis